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Abstract
Lupus is a multi-system autoimmune rheumatic disease with increased morbidity and mortality. Some manifestations are 
life-threatening with many aspects of living with the disease, difficulties in diagnosis and accessing appropriate medical care, 
having an impact on quality of life. The disease itself, and these patients’ perspectives, are currently poorly understood and 
under-researched. The LUPUS UK forum of conversations between over 25,000 members provides a rich environment to 
explore the views of these patients. Conversations on the LUPUS UK online forum were qualitatively explored using virtual 
ethnography and thematic analysis. The forum itself and positive medical relationships were widely considered to provide a 
means of support, understanding and validation. Forum members expressed difficulties in diagnosis, disease management, and 
the psychological and physical impact of living with an unpredictable, poorly understood disease, often with life-changing 
symptoms. Invalidating personal, social and medical environments were perceived as exacerbating these difficulties. Delays 
in diagnosis and misdiagnoses were frequently discussed as causing significant damage, especially when symptoms were 
disbelieved or dismissed. Invalidation was the key theme with further themes of: Uncertainty, Medical (mis)communications 
and misunderstandings, Navigating health systems and Resilience and support. Although effective care and support was 
reported by some members, the negative impact of living with an incurable, life-changing disease was often exacerbated by 
perceived invalidation, uncertainty, and difficulties in multiple areas of members’ lives. Improved knowledge of the disease 
and greater support at all stages of the diagnostic journey could improve outcomes and quality of life for these patients.
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Introduction
Systemic lupus erythematosus (SLE) is a chronic multi-sys-
tem autoimmune rheumatic disease [1] causing significant 
morbidity and mortality [2, 3]. In addition, there is often a 
severe impact on quality of life (QoL) [4, 5]. This includes: 
increased prevalence of multiple neuropsychiatric manifesta-
tions [6–8], employment difficulties [5, 9], and debilitating 
fatigue [5, 10–12]. The unpredictability, lack of understand-
ing/recognition of the disease and diverse manifestations 
generate additional challenges for patients and physicians.
Lack of definitive tests means diagnosis and management 
largely relies on individual physician knowledge, with many 
studies reporting inadequate training and knowledge [13, 
14]. Delays in diagnosis and misdiagnoses are common with 
previous studies reporting an average of 6–7 years to diagno-
sis [11, 12, 15], and approximately 50% of patients initially 
misdiagnosed [11, 12].
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Our previous research has found that diagnostic difficul-
ties and negative medical interactions can generate persisting 
psychological damage and insecurity, particularly amongst 
those who were met with disbelief or were given psychoso-
matic or mental health (MH) misdiagnoses [11, 16].
Despite the World Health Organisation (WHO) increas-
ingly recognising the importance of wellbeing, and encour-
aging governments to provide education and tools for self-
management and care in chronic diseases [17], many patients 
with lupus report that there is limited self-management edu-
cation. They thus often rely on peers for knowledge transfer 
and emotional support. Peer support from those who expe-
rience the same challenges of living with the same chronic 
health condition [18, 19] is increasingly a focus of research.
Previous studies have identified a need to focus on QoL 
and holistic care [20, 21], increased awareness of the wider 
needs of this patient group [4, 5], and the impact of the 
patient–physician relationship [16, 22].
Forum analyses are increasingly used in qualitative 
research [23] as a cost-effective method of analysing the 
experiences of thousands of patients to find common themes. 
The LUPUS UK forum has over 25,000 members with mul-
tiple conversations and opinions of a large group of patients 
who are communicating openly with peers. This forum anal-
ysis will build on our previous work [11, 16] with the aim 
of giving these patients a wider combined voice, and iden-
tifying unmet needs, values, concerns and preferences, thus 
enabling patient-centred improvements to be considered.
Methods
Participants
Demographic information is limited as the majority of par-
ticipants use pseudonyms. The site moderator, LUPUS UK, 
estimates that the vast majority of active members are from 
the UK and have SLE. The site also includes patients with 
related autoimmune diseases such as undifferentiated con-
nective tissue disease (UCTD), Sjögrens, and in the diag-
nostic uncertainty stage. The analysis included all active 
members of the forum. From November 2018 to January 
2019, there were an average of 2649 active (posting at least 
once) members per month representing 11.8% of the 22,484 
members as of 6 February 2019.
Data collection and analysis
Two methodological approaches were combined to study 
this population. First, virtual ethnography [24], where seven 
members of the research team were fully immersed in the 
community, either as patient members or moderators. These 
researchers had a total combined time in the community of 
over 30 years. Second, forum posts were analysed themati-
cally in reverse chronological order from October 2019 until 
theoretical saturation was reached with no new concepts 
emerging [25] (March 2019). This involved (1) developing 
and agreeing a broad coding scheme, (2) coding the data, 
(3) combining and comparing the posts/responses with other 
quotes on the same theme, (4) refining and re-coding, (5) 
identification of commonly occurring themes [25], and (6) 
further review of selected relevant historical posts as far back 
as September 2012. Particular attention was paid to deviant 
findings to strengthen validity of the findings [26]. Ethical 
approval was obtained through the Cambridge Psychology 
Research Committee—PRE.2018.120. Permission to quote 
individuals was obtained by LUPUS UK staff. Questions to 
clarify that emerging themes fully reflected the members’ 
experiences, and later the draft paper, were posted on the 
forum to discuss and agree key findings with the community.
Further details of methods, ethical considerations and 
researcher reflexivity can be found in supplementary infor-
mation 1.
To ensure that the qualitative analysis also reflected the 
quantities of subject matter posted, five co-authors carried 
out content analysis of a month of forum posts each (ran-
domly generated from January 2016 to April 2019).
Results
The six most frequent types of posts (as a % of total posts) 
were (1) asking for advice on symptoms, 18%; (2) negative 
medical appointments/interactions, 17%; (3) medication/test 
results queries, 15%; (4) general advice given/sought, 13%; 
(5) emotional/mental health/struggling to cope, 8%; and (6) 
search for diagnosis, 7%. The ratio of positive to negative 
posts discussing medical interactions was 1:6.5.
The overarching theme was Invalidation in multiple 
domains (medical, societal and self) of forum members’ 
lives. Further themes included: Uncertainty, Medical (mis)
communication and misunderstandings, Navigating health 
systems and Resilience and Support.
Invalidation: medical
In addition to ensuring appropriate support and treatment, 
a diagnosis was widely felt to confer personal, medical and 
social acceptance, yet delays and misdiagnoses were fre-
quently reported.
While many members reported severe manifestations 
of the disease including organ damage, early symptoms 
reported on the forum were often non-specific, such as 
migrating pain, severe fatigue, fevers and rashes. A desire 
for physicians to persist in ‘joining the dots’ in pursuit of 
the correct diagnosis was frequently expressed. Although 
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some achieved prompt diagnosis, the diagnostic journey was 
widely reported to be extremely invalidating and distress-
ing, with words including ‘unheard’, ‘rejected’, ‘shame’, 
‘guilt’, ‘dismissed’, ‘desperation’, ‘fear’, ‘abandoned’ fre-
quently occurring, along with reports of a loss of dignity 
and self-worth.
Some forum posts detailed how individual physicians pro-
vided compassionate support during the years in the ‘diag-
nostic wilderness’. However, a more frequent type of post 
was when the continued search for a diagnosis was reported 
to have led to misdiagnoses of health anxiety/hypochondria, 
psychosomatic or mental health issues. Posts detailing these 
misdiagnoses often expressed great distress and distrust, and 
a perception that patients’ self-reported symptoms were not 
always believed or validated, including post-diagnosis.
Patient quotes of experiences of medical invalidation, 
including opposing validating experiences of a diagnosis 
and supportive physicians, are shown in Table 1.
Invalidation: societal
The frequent lack of medical clarity, a widespread lack of 
knowledge about the disease and the invisibility of many 
symptoms resulted in posts about limited understanding and 
disbelief in the reality and severity of symptoms from patient 
contacts and wider society, with members often being told 
“but you don’t look sick’’. This was reported to have caused 
difficulties with family, friends, work, and school, resulting 
in posts about relationships being severely challenged and 
sometimes failing.
Similar problems led to significant hardship and distress 
when applying for and using welfare benefits and conces-
sions such as Blue Badges. Forum members often reported 
being disadvantaged compared to more visible or widely 
understood conditions such as cancer, rheumatoid arthritis, 
diabetes and hypothyroidism, in terms of treatment, medical, 
and social support systems.
Invalidation: self
The consequences of the organic disease itself were con-
siderable. Some members expressed a deep sadness and 
felt that they were a reduced version of their previous self. 
Many were unable to work, socialise, or fulfil their car-
ing roles as they would like. Forum members, particularly 
those with young children, commonly felt guilt and lowered 
self-worth. Managing and accepting these chronic diseases, 
medications, limitations and building relationships with phy-
sicians was often felt to be hindered by traumatic diagnostic 
journeys and by having a diagnosis that remained subject to 
change, progression and uncertainty.
Fatigue was regularly described as extremely debilitating 
and isolating, predominately due to causing an inability to 
participate fully in life, but also due to the incomprehensibil-
ity of those who have not personally experienced it. Physi-
cians and people without chronic diseases expressing, or 
implying, doubt that this pathological fatigue could be far 
more profound than ordinary tiredness left many members 
feeling inadequate and ‘lazy’.
Table 1  Medical invalidation/validation quotes
The importance of viewing symptoms holistically in achieving a diagnosis
 The sense of blackness that would pass over me at appointments, fearing the nothing wrong statement or just ‘anxiety’. The despair of walking 
away with no help still feeling very ill and with no life. Just that one consultant who looks deeper and changes things for the better… When 
the dots are joined up it makes a big difference to quality of life. There are some great dedicated doctors out there and they really are trying 
very hard to help us (Female, UK, 50s)
 My final diagnosis was very quick…thanks to an amazingly observant GP – but in hindsight I realised I had had lupus for years before that but 
because the symptoms all appeared separately nobody pieced the jigsaw together. Lupus is notoriously hard to diagnose because it affects 
everybody differently and there are so many different symptoms (Female, 70s) 
The ‘fight’ for validation of multi-system symptoms that fluctuate over time
 You’re fine and then suddenly something is wrong and you know it, but instead of a straightforward test and answer, you have to fight to be 
believed, then it goes this way and that from one department to another and back again and not everyone is on the same page and you have to 
explain everything to every consultant every time (Female, England, 50s)
‘Relief’ and validation on diagnosis
 For me it took about 10 years to diagnosis…I kept thinking I was just a tired unmotivated person. It was a relief to get the diagnosis because 
you stop thinking you are crazy or imagining symptoms (Female, US, 60s)
The psychological benefits of validation during the—often prolonged—diagnostic uncertainty phase
 [GP] was the best example of a compassionate, intelligent and very wise Doctor giving me the wonderful care and sympathy despite no defini-
tive diagnosis. A positive Doctor gives as much psychological support as any drug (Female, UK, 60s)
Residual distress and anger towards physician(s) due to disbelief and invalidation during the diagnostic journey
 Did my illness make me this unwell or did my battle to be heard make me this unwell, maybe the battle just depletes us… I just completed a 
self referral for counselling. I think now I have some answers it’s time I dealt with the problems this journey has caused me. I’ve got such a 
build up of hate and anger towards 1 doctor! (Female, England, 30s)
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Reductions in physical abilities were often compounded 
by cognitive impairment, causing difficulties in work and 
relationships. Changes to appearance caused by the disease 
itself (for example, from skin involvement) and from medi-
cations (particularly weight gain from steroids) were also 
discussed as distressing and highly damaging to self-esteem.
These features were often exacerbated by an internalisa-
tion of the invalidating attitudes of others. Many reported 
that the initial disbelief they encountered from physicians 
made them doubt their own judgement—even their ‘san-
ity’. The vast majority of forum posts following a diagno-
sis expressed great relief on having an explanation for their 
symptoms: of validation and vindication.
Table 2 includes participant quotes documenting the 
emotional and psychological damage from societal and 
self-invalidation.
Uncertainty
Living with an unpredictable multi-system disease subject 
to relapsing, remission, progression and evolution of symp-
toms caused great uncertainty and difficulties in planning 
and managing lives daily and long term.
A stable and unchanging diagnosis was widely considered 
as being important to acceptance. Uncertainty seemed espe-
cially difficult to accept by the newly diagnosed, and they 
were often guided by supportive posts from moderators and 
experienced members.
A perceived lack of consistency in diagnostic criteria and 
terminology—even within the same rheumatology depart-
ment—created great uncertainty and insecurity among 
patients. There were multiple reports of a diagnosis that had 
been removed or changed, and life-changing medications 
withdrawn. This was often perceived to be due to a change of 
rheumatologist, or an over-focus on (often inaccurate or out-
dated) test results, despite symptoms remaining unchanged.
Medical (mis)communications 
and misunderstandings
Members reported basic misunderstandings of the disease, 
both by themselves and physicians, especially in the early 
stages of diagnosis. Although some received clear explana-
tions, many felt they were given limited information, with 
the forum frequently consulted on symptoms, test results 
and medications.
The contents of face-to-face communication, clinic letters 
and reports were frequently discussed. A failure to empa-
thise, to acknowledge patient concerns, and to include the 
patient in the sharing of all results and reports were often 
identified as a source of frustration and disempowerment.
Table 2  Societal and self-invalidation
Invalidation and loss of dignity from difficulties obtaining welfare (Personal Independence Payments –PIP) disability benefits
 The whole [PIP] process is degrading and mentally painful. Why is it a matter of guilty until proven innocent I don’t know. Maybe we’ve 
moved beyond the ‘treated with dignity and respect’ mantra..the feeling of being thought of as a scam artist or downright liar is worse than 
losing the money (Female, England, 60s)
 My PIP was stopped, we are barely surviving…British Gas are on my tail…motability given me a date to reclaim my car. I am tired, the way 
and manner the PIP rug is pulled off one is horrible. I want to work but I’m not well enough…the stress that comes with the benefits system, 
slowly chips your life away even before the lupus gets to you.(Female, UK, 30s)
Lack of understanding and societal support for lupus compared to more well-known diseases
 I feel ashamed that I’ve thought it myself, that cancer would be better…it has such a huge lobby (researchers, charities, specialist status in 
law…) and most of all, everyone has empathy for someone with cancer (Female, Scotland, 50s)
Impact of the changes to appearance and reduction in quality of life for patients and their families
 The weight gain, hair loss, teeth loss. On and on and on! I feel so pathetic, and ugly, and embarrassed by my appearance, I try to walk tall and 
act like I don’t care, but I do. It’s humiliating. The giving up all the activities I love. Missing out on so much and feeling I’m ruining my 
husband’s life too (Female, USA, 60s)
Over-whelming fatigue and subsequent guilt and self-invalidation
 Feel like the worst parent in the world, my poor kids…I’m sat there literally dying from fatigue…. It’s like wasting life …I just feel like giving 
up…I feel so useless and look at the mess in the house and the kids in their pjs all day and feel like a useless mum (Female, England, 40s)
Suicidal thoughts and a loss of self-worth from lack of diagnosis and support
 I’ve been in a very low place too when nobody seemed to understand what was wrong with me and worse still didn’t seem to care!! I felt 
worthless. I too thought of ending my life and had to get emergency counselling as well as medication for severe depression. (Female, Scot-
land, 60s)
Feelings of worthlessness from invalidation and loss of former identity
 At what point does one’s use in the world expire with this disease. So, if it takes away my love of walking, writing, thinking, functioning, being 
free, spending quality time with my daughter, what is left of ’me’ and do I become a ’burden’…lost and worthless…my quality of life is 
slowly dropping away—everything that I am seems to be disappearing in this horrible set of conditions I have and the awful way we have to 
prod and poke the medical profession to help (Female, UK, 50s)
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Miscommunication was found to often exacerbate 
other concerns. Labels such as UCTD and ‘incomplete’ 
lupus were sometimes felt to be poorly explained and not 
a ‘proper’ diagnosis. While reassuring to some, ‘mild’ 
lupus was felt to be dismissive to many who reported that, 
although they understood it may mean non-organ involve-
ment, it felt undermining given the extent of their life-
changing symptoms.
Many members accrued additional symptoms and 
autoimmune diagnoses over time and largely accepted 
that is the nature of autoimmunity. Some were given non-
inflammatory diagnoses such as fibromyalgia, functional 
disorders or ME/CFS, usually as co-diagnoses which some 
members accepted could be an accurate representation of 
some symptoms. However, many strongly felt these that 
were ‘fobbing off’ misdiagnoses given by physicians felt 
to be ‘guessing’ due to insufficient knowledge of complex 
autoimmunity, with little/no discussion, objective evi-
dence, or scientific rationale.
Table 3 contains some Forum members’ quotes high-
lighting common issues with uncertainty and medical 
communications.
Navigating health systems
Although some reported that support was quickly avail-
able, there were more frequent posts detailing difficulties 
accessing medical support, ‘gatekeeper’ receptionists/GPs, 
irregular and postponed appointments and declined refer-
rals. Patients and physicians were often perceived as being 
trapped in an inefficient, over-burdened system. There was a 
widespread sense of injustice that limited reserves of physi-
cal and mental energy were required not just to ‘fight’ the 
disease, but also in overcoming barriers to obtaining medical 
support, both pre- and post-diagnosis.
Geographical inequalities in care were regularly dis-
cussed. In particular, members in parts of Wales dis-
cussed a perception of poor local rheumatology services. 
These members, and others, reported great distress—and 
Table 3  Uncertainty, medical (mis)communications and misunderstandings
The desire for a named and acknowledged disease to explain life-changing symptoms
 I just find it frustrating not to have a name for the disease that has pretty much ruined my life (Female, UK, 30s)
Difficulties from changing diagnoses
 So after being told I had lupus, telling my employer and getting the sack over it, a 2nd rheumatologist said it was UCTD. No one has bothered 
explaining anything (Female, Wales, 30s)
Great appreciation for physicians managing diagnostic uncertainty compassionately
 He went on to say sorry… it gives you no answer but lovely to meet you and I wish you well and hope you find the doctor with the answers, 
I’m sure it’s there it’s just knowing who to see. So still no answers but treated like a human being… could have hugged him… just plain 
honesty and empathy and it was a heavenly change of experience. (Female, UK, 50s)
Frequent misunderstandings of these diseases leading to diagnostic delays and misdiagnoses
 (GP) said if I had lupus my kidneys would be involved (Female, Canada, 60s)
 He [GP] hadn’t heard of the dsDNA test [positive]… I was prescribed antidepressants…after frequent visits he concluded ‘you’re a glass half-
empty kind of person’. (Female, Scotland, 50s)
Difficulties interpreting and/or accessing test results
 I don’t even know what tests each doctor has done. If I don’t ask they either don’t tell me or dazzle me with stuff I have no idea about they may 
as well be speaking Chinese (Female, Scotland, 50s)
 If a GP cannot interpret a result, that’s their problem- they shouldn’t use that as an excuse to withhold it from me. Likewise for a consultant to 
withhold a result because they think I cannot be trusted with it is paternalism gone mad…I cannot tell you how much better I feel having got 
the blood results in my hand – even if they aren’t the best. Being denied information about your own illness is completely undermining—and 
wrong. (Male, Wales, 50s)
The importance to patients of compassionate, attentive communication verbally and in writing
 I’ve just received my rheumy review letter and am really down and very tearful…feel hopeless and helpless suddenly. I’ve plummeted on 
reading this cold letter…I know we are a miniscule (and clearly forgettable) person in their lives, they have such huge caseloads… but after 
3–4 months of waiting what they say and write afterwards means so very much (Female, UK, 50s)
The view that autoimmunity is widely misunderstood leading to over and misdiagnosis of non-organic syndromes
 As I frequently drag my collection of body parts around multiple ‘ologies’ I do wonder when it was that I stopped being…well…a systemically 
connected human body. I ‘m not denying that conversion or functional disorders exist…just that these labels are often too easily plucked out 
of nowhere…often through lack of rigour, willingness or the time to get to the root cause of what I believe are some of the trickier symptoms 
of autoimmune disease (in all their ugly guises) (Female, England, 60s)
 I’m increasingly incensed and hope to lobby for the word functional to be challenged until all the established and newer methods of testing for 
organic conditions are available to all in UK. Particularly for those of us in the devolved nations who can’t even access London testing due to 
not having a right to an out of Scotland/Wales second opinion (Female, Scotland, 50s)
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sometimes irreversible organ damage—with frequent 
descriptions of being refused access to SLE specialists 
due to ‘gate-keeper’ policies.
Personal characteristics were discussed as influencing 
diagnosis, especially apparent among female members 
perceiving that physicians may be more inclined to give 
psychological/MH misdiagnoses like ‘anxiety’ and ‘stress’ 
based on their gender and stage in life. As many became 
symptomatic in the child-rearing years, the stress of ‘being 
a new mum’, ‘having teenagers’, etc., were sometimes ini-
tially given as reasons for their symptoms, with symptoms 
in older females often attributed to the menopause, age-
related decline and in one member ‘empty nest syndrome’. 
However, although males are much in the minority as SLE 
patients and on the forum, their conversations revealed that 
their diagnostic journey was often no easier.
A proportion of UK patients reported that diagnostic/
care difficulties or NHS waiting times led them to seek a 
diagnosis from SLE specialists privately, creating diag-
nostic and treatment inequalities between socioeconomic 
groups.
Much appreciation was expressed for rheumatologists 
who took the holistic view of the patient and co-ordinated 
highly effective multi-disciplinary care. Conversely, frus-
tration was expressed when symptoms were not seen sys-
temically, or medical specialisms seemed to treat the patient 
as a collection of unconnected body parts. Some members 
complained that they felt passed ‘like an unwanted parcel’ 
around the ‘ologies’ with ‘merry go rounds’ of superficial 
investigations that failed to take account of the complex and 
difficult to detect manifestations of SLE/CTDs. Members 
reported being regularly discharged with ‘reassurance’, yet 
leaving them with debilitating and/or concerning unex-
plained symptoms, until tests verified the patients’ experi-
ences. This occurred both pre- and post-diagnosis and added 
to the perception of invalidation and self-reported symptoms 
not being believed.
Table 4 contains quotes of positive and negative experi-
ences of accessing appropriate care, including multidiscipli-
nary care, inequalities and administrative failings.
Resilience and support
Close working relationships with physicians were reported 
by many members, often with such an overwhelming feeling 
of relief and gratitude to the clinician(s) who diagnosed and/
or gave them compassionate care that they were frequently 
described in terms of being ‘stars’ or ‘heroes’ with a feeling 
of great security and attachment.
Honest and empathetic communication from physicians 
was highly valued, with many posts highlighting the impor-
tance of listening with compassion to a patient’s subjective 
experiences. The importance of the role that allied health 
professionals, such as nurses and physiotherapists, play was 
discussed. Members reported many positive interactions, 
and a perception that such professionals may have more time 
to focus on listening to the patient, and helping with the 
practical challenges of the disease.
Some members reported how diagnosis, medical sup-
port and acceptance gave them strength and allowed them 
to validate their own symptoms by listening to their bodies 
and pacing activities. Many members also detailed support 
from family members and friends, both practical and emo-
tional. Although lives were clearly substantially altered by 
the disease, there were regular inspiring posts by members 
who were finding a sense of purpose and achievement by 
adapting activities around the limitations of the disease.
The forum itself tended to be discussed in extremely posi-
tive terms. It performs several complementary functions, 
including facilitating friendships and reducing isolation 
and loneliness, with active moderators ensuring a safe and 
respectful environment. Members shared symptoms and 
problems and exchanged knowledge, research papers and 
tips on managing both the disease and medical encounters. 
Table 4  Navigating health systems
The impact of cancellations and difficulties accessing medical care
 To them it’s a cancelled appointment, to me it’s my life (Female, England, Teens)
 I’ve no letter and no booking for my next appointment. There are no lupus nurse appointments and no one’s answering the telephone. I know 
things are terrible in hospital but it doesn’t alter how horrible it feels to be abandoned…the horrible irony of it all is if we got more preventa-
tive services before we got critical our care would be a lot cheaper and we’d be more likely to be working…I just feel too tired to keep on 
saying the same thing over and over. (Female, UK, 50s)
Views on inequalities of care
 I also live in wales and can echo the woeful lack of awareness, facilities, therapies, access to care and support! (Female, Wales, 30s)
 Apart from being female, it was pretty obvious that me being relatively poor, impaired by trauma, illness, brain fog and being unable to think 
quickly on my feet made it near impossible to get the time required for appropriate SLE care (Female, Australia, 50s)
Experience of co-ordinated multidisciplinary care
 Despite the negative bloods, I had a few years of remarkably enlightened consultants who kept each other in the loop and worked together on it 
(Female, UK, 40s)
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This often led to improved medical confidence and medical 
relationships.
Table 5 contains forum member quotes highlighting the 
great value placed on empathetic physicians and the LUPUS 
UK forum in providing compassionate support.
Figure 1 gives examples of three forum members’ diag-
nostic journeys, highlighting the damage caused by delayed 
diagnosis and ‘disbelieving’ physicians, and the redeeming 
impact of supportive physicians and peers.
Discussion
A feeling of relief was usually described as the overwhelm-
ing emotion on diagnosis. Considering SLE is often a life-
changing, sometimes life-threatening, incurable disease with 
many unpleasant manifestations, this is a strong indication of 
the degree of trauma often suffered on the journey to diag-
nosis and the desperation for medical help and validation. 
This research has identified that many forum members expe-
rienced a distressing combination of life-changing symptoms 
with often traumatic diagnostic journeys and a perception of 
invalidation in multiple areas of their lives.
Initial symptoms were often reported on the forum as 
appearing sequentially and insidiously, with patient and 
physician encountering difficulty in identifying an under-
lying disease process frequently leading to misdiagnoses. 
Those in the ‘not yet correctly diagnosed’ stage are clearly 
a highly vulnerable, often medically neglected group, at risk 
of potentially irreversible damage to their physical and men-
tal health.
SLE is often reputed to be an ‘invisible’ disease with both 
social and medical diagnoses seemingly reliant upon visual 
indicators of disease, with an often prolonged period of time 
before symptoms are validated by a diagnosis [27]. Valida-
tion is a key theme identified in both the existing literature 
and this research. Santiago et al. found that invalidation in 
all rheumatic diseases was associated with psychological 
factors, loneliness and greater pain, and requiring interven-
tion [28]. Our research has added greater depth to previous 
research findings, that the lack of perceived consideration 
for subjective symptoms leaves many patients feeling disbe-
lieved and dismissed [11, 16, 29, 30] and remains an ongo-
ing issue. Price and Walker found that for some, the SLE 
diagnostic journey can reflect the nature of the disease in 
terms of uncertainty and ‘chaos’ [31]. Our study is in agree-
ment, and has provided additional evidence, to findings of 
studies of other rare diseases that the search for diagnosis 
can be very distressing and finally obtaining a diagnosis can 
be extremely validating [32].
In agreement with our previous research [11, 16], we 
found that mental health/psychosomatic misdiagnoses were 
perceived as particularly damaging, resulting in posts dem-
onstrating insecurity and fear of physician disbelief even 
in subsequent positive medical relationships. Many forum 
participants reported that they eventually lost their self-
belief and questioned their own sanity with examples given 
of how this led them to avoid seeking medical help. This 
was also found in a study of parents of children with auto-
inflammatory disease where they reported doubting their 
own judgement in the face of medical disbelief. As in our 
study, this generated a persisting distrust of clinicians even 
after diagnosis [33].
Many patients reported that referrals and diagnosis were 
delayed by common misunderstandings, including that 
lupus can only be diagnosed in females with positive anti-
dsDNA, ANA, malar rash and kidney damage. Previous 
research demonstrates longer delays to diagnosis reported 
Table 5  Resilience and support
Supportive medical relationships
 Mine (‘star GP’) once phoned me at 7 pm on a Friday night to check I was OK! …he always books me in for his last appointment as he doesn’t 
want me to feel rushed (Female, Scotland, 40s)
 My wonderful consultant watched as I cried in her office [on dx with SLE]. I asked why she believed me when I’d been dismissed as an awk-
ward patient ‘because when a patient tells me something I choose to believe them’ (Female, England, 30s)
 I feel I have had the best of treatment and have been shown understanding, compassion and also been involved in the development of my treat-
ment plan. (Female, UK, 70s)
Learning to adapt to the limitations of the disease, with compassionate guidance from clinicians
 I went to get some physio and she was so positive ‘we will get you back into shape’ and she was a great listener…. I thought I really need 
encouragement right now and positive speak (Female, Wales, 50s)
 I was very tearful…she [lupus nurse] was very kind…held my hands and said all of this has unsettled your Sjögrens, no wonder you feel so 
low. Walking out of there I already felt a little uplifted. Nurse did not mention antidepressants, give an eye roll, look at her watch…she gave 
compassion, understanding and reassurance. (Female, UK, 60s)
The value of peer support and understanding obtained from the forum
 We all hit that wall of despair, but if we let each other know, as you all always do, that there are those who care, who can lift us for the moment 
so we can shake it off and keep going, I think it helps see us through…I can’t tell you how many times I’ve read posts and have cried, been so 
angered, or laughed, and felt inspired by all of you! (Female, 60s, US)
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Diagnosc Difficules  
                 Female, 30s                                                                   Female, 60s                                                             Female, 40s                     
Impact of the disease and/or diagnosc difficules
Benefits of peer support and effecve, compassionate medical care
The doctor I used to see was so 
adamant that my symptoms were 
psychosomac…I paid for a lot of 
private therapy.
Medics all insisted there was NO UNDERLYING condion 
involved in my health stuff. Being a bit in awe of medics and 
condioned by tradional paternalisc health care culture I 
did start by respecng them, then felt conflicted, a sense I 
was actually being abused by a system that wasn’t 
considering my case holiscally…isolaon, anger and fear 
grew… GP was irritated and indignant when I insisted on 
rheumy referral. As I thanked her and turned to leave I said I 
don’t want to have lupus, I just think it’s about me we find 
out what I do have.
Finally diagnosed 2 weeks ago 
with lupus, fibro and Sjogrens 
aer almost 5 yrs, 2 GP 
surgeries and a second opinion 
from a great rheumy team.
I can see how damaging this 
process has been for my 
confidence. Things went on so 
long that I started to doubt my 
own sanity!...I completely lost 
the ability to stand up for myself 
or discuss my concerns.
The medical PTSD caused by those horrible 40 
years [undiagnosed] connues to haunt me so 
badly that I am constantly expecng the NHS to 
wash it’s hands of me…irraonal but inevitable 
aer decades of negligence… Now I have to 
manage it hour by hour, negligence, suffering, 
trauma…
It’s been a tough bale, not just 
with physical problems, pain, 
chronic fague and depression but 
psychologically draining being made 
to feel like I’m a whinging 
hypochondriac who le many many 
GP visits in floods of tears being told 
my pain was in my head.
The forum has helped keep my confidence 
up long enough to make sure I’m really 
being heard…Having a doctor who listens 
makes such a huge difference. And being 
on here has really helped me to remember 
that I’m not crazy and I know my own 
body.
Find myself well and truly locked into 
an NHS muldisciplinary approach...I 
keep pinching myself…I am clearly 
benefing from this approach [but] I 
sll can’t even begin to feel safe or 
secure…anxiety will never leave 
me..years of therapy have helped..but 
what REALLY HELPS is your good 
company [forum] we all have so much 
in common
You have all given me the strength to 
follow my insnct and persevere to get a 
2nd opinion..not only did [rheumatologist] 
make me feel like my symptoms were real 
he also gave posivity to look forward to 
having some kind of future when I felt like 
throwing the towel in. If it wasn’t for this 
group I don’t think I would have had the 
confidence to ask for a second opinion and 
would sll have been stuck in a really dark 
place. Who knew a mere mortal could 
queson an expert’s opinion
Fig. 1  Examples of three typical diagnostic journeys
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in children, males and late-onset cases [34], and in ANA-
negative patients [11]. Although SLE is more prevalent in 
females of child-bearing years with a Female:Male ratio of 
9:1 the disease affects both genders, all ages and there are 
multiple other presentations, symptoms and immunological 
criteria for diagnosis [1, 35, 36].
The complexity and varied presentations of SLE and 
other related autoimmune diseases causes difficulty with 
the desire for clarity and certainty [37, 38]. Uncertainty and 
the strongly expressed desire for a clear diagnosis may be 
better managed by improved physician communication as to 
the unpredictability and evolving nature of these diseases. 
Lack of definitive diagnosis or delay in provision of treat-
ment for debilitating symptoms is distressing for patients 
yet may have a well-considered medical reason, for exam-
ple, the necessity to consider other potential causes and the 
balancing of risks versus benefits of medication. This forum 
analysis has demonstrated the great appreciation for those 
physicians who clearly and compassionately communicate 
the rationale behind these decisions and provide support 
with symptoms, regardless of presumed cause. Reports of 
dismissal and disbelief by clinicians unable to discover a 
cause for a new symptom were frequent, and their offers 
of reassurance rarely inspired confidence. Even those with 
long-standing disease reported misdiagnoses or no explana-
tion—or treatment—for new, rarer [39–41] manifestations, 
particularly from those physicians who were felt to focus 
only on the more common symptoms affecting joints, skin 
and kidneys. Early signs of rarer manifestations were often 
under-investigated and undetected, until they progressed to 
become obvious on current (often perceived as inadequate) 
testing, sometimes coinciding with irreversible organ dam-
age, including sight or hearing loss, intestinal failure and 
brain damage.
Improved communication and support for any co-diagno-
ses may also assist in acceptance and trust in cases where a 
co-diagnosis is accurate and helpful in terms of differentiat-
ing from active SLE for disease and symptom management. 
While acknowledging the very real and distressing nature 
of conditions with no current definitive testing, such as ME/
CFS and fibromyalgia, many forum participants remained 
extremely sceptical as to the validity and acceptability of 
these as co-diagnoses in the context of autoimmune diseases, 
when pain, fatigue and sensory disturbance are also a regular 
manifestation of the primary disease.
There was a strong perception of geographical, socioeco-
nomic, gender, age and disease inequalities of diagnosis and 
care, particularly regarding the Welsh gate-keeper policy. 
Following the BSR guidelines [1] could reduce multiple ine-
qualities by improving knowledge and consistency in refer-
rals, diagnosis and management. The perceived lower level 
of medical and social support compared to other diseases 
needs consideration. Although the changes to the British 
welfare system have adversely impacted many chronically 
diseased patients, the invisibility and relapsing–remitting 
nature of the disease, the lack of diagnostic certainty and 
lack of understanding regarding SLE by both physicians and 
welfare assessors, potentially causes greater problems for 
these patients accessing appropriate financial support. These 
differentials of power are reported in previous studies [42, 
43], with difficulties accessing welfare during diagnostic 
journeys, potentially due to distrust in the welfare system of 
those lacking a definite diagnosis [42], and Whitehead and 
Williams hypothesising that female lupus patients struggle 
to be taken seriously, being ‘doubly burdened’ by gender and 
diagnostic uncertainty [43].
In addition to difficulties obtaining diagnosis and care, 
forum members also discussed the many negative conse-
quences of the disease on their quality of life. Severe fatigue, 
pain and cognitive difficulties were most regularly men-
tioned, often causing difficulties with employment and rela-
tionships. As with other studies of chronic illness, we found 
that self-worth and self-identity are frequently damaged due 
to an inability to fulfil social [44] and caring roles.
This study has identified that the support provided by 
the forum, LUPUS UK and by empathetic physicians, fam-
ily and friends helps mitigate invalidation and uncertainty. 
Clinicians providing emotional support and listening to 
patient’s symptoms non-judgmentally is highly valued by 
forum members. By presenting the patient perspective in 
this paper, we hope that clinicians will further consider the 
great impact on patients of physician communication styles 
and validation of patient symptoms. Irrespective of the final 
diagnosis, patients need to feel that their concerns are being 
taken seriously and that they are supported in managing their 
symptoms. This may mean sign posting to other services to 
help support the patient if the clinic lacks time/experience 
in the management of all symptoms, particularly those that 
may be multifactorial in origin.
Emotional support and the sharing of experiences is 
an important function of all patient groups, whether face-
to-face or online and was highly valued by this group of 
patients. In agreement with other studies, we found that peer 
support helped people through interactions with others in 
similar situations, often by promoting self-esteem, improv-
ing self-worth [45], and reducing isolation [27]. In addi-
tion, we identified that group norms of mutual support and 
empathy were also found to enhance emotional resilience. 
Our findings were in line with Basu and Dutta’s study [46] 
that online communities can increase medical knowledge 
through health-related discussions.
Many of the LUPUS UK forum members demonstrated 
a high level of medical knowledge and shared up-to-date 
research, with multiple posts detailing how knowledge and 
empowerment gained through the forum assisted in diagno-
sis and improved care. However, the large quantity of posts 
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requesting information on deciphering blood test results, 
medication enquiries, symptoms and misunderstandings of 
the disease, particularly among new members, may point to 
the need for more information and clearer explanations from 
clinicians, especially at diagnosis.
A strength of this study is that the forum enabled a much 
larger quantity of viewpoints to be analysed than traditional 
qualitative methods. Views stated are more likely to be free 
from social desirability bias as there was no researcher or 
physician influence on conversational direction [45]. The 
24-h forum accessibility means that experiences and emo-
tions are often reported immediately so less subject to recall 
bias. The limitations are that the results may not be repre-
sentative of the wider SLE population due to demographic 
and experience bias. As with all qualitative research, the 
results cannot be generalised to the wider SLE population, 
although the large size of this group makes this less of a 
limitation than in traditional interview-focused research. 
There is limited demographic information, diagnoses are 
self-stated and cannot be confirmed, and disease severity, 
including organ involvement, is not always apparent from the 
conversations. Members may be those with more negative 
experiences who are in need of greater peer support. Nega-
tive and invalidating medical experiences may be reported 
more frequently than positive ones as patients seek valida-
tion from peers. In addition, patients who have had poorer 
explanations or persistent confusion about their disease 
may be more likely to post comments. While a limitation 
of forum analyses is the inability to request clarification on 
members’ experiences, we were able to reduce this limita-
tion by discussing the research on the forum, posing ques-
tions and sharing research findings to ensure the themes 
identified were validated by the community.
In conclusion, whilst we cannot extrapolate these results 
to all SLE/systemic autoimmune patients, the overarching 
theme is chronic invalidation with patients who often felt 
poorly served—and in some cases, damaged—by health 
systems, with fragmented care and a lack of knowledge 
about the disease amongst society and many physicians. 
Support for the much-reduced quality of life could be 
improved by more access to specialist support (e.g. spe-
cialist nurses, physiotherapy and psychosocial support), 
signposting of all patients towards relevant charities, and 
developing additional methods of self-management edu-
cation and peer support. Improved support for all patients 
with initially medically unexplained symptoms is an urgent 
requirement; not only to avoid damage from psychogenic 
misdiagnoses, but also because a medical—and potentially 
treatable—explanation was usually subsequently discov-
ered in these patients after more detailed testing or consul-
tation with appropriate specialists. This study highlights 
the importance of earlier diagnosis, cross-specialism sup-
port and empathetic communication. In addition, there is 
a need for more appropriate and prompt investigations in 
those diagnosed, as not all new symptoms should be auto-
matically attributed to the primary autoimmune disease yet 
ANY new sign or symptom could be related to systemic 
autoimmunity.
Acknowledgements This research was carried out with frequent 
discussion and active input from patients, LUPUS UK and rheuma-
tologists. Multiple patients contributed throughout the research with 
a group of 4 active forum members regularly communicating with the 
wider research team to discuss forum posts, patient priorities, emerg-
ing themes and share knowledge. All interested parties were involved 
throughout the research, including in reviewing the paper pre-publica-
tion. The draft results and discussion sections of this paper were posted 
on the forum for members’ suggestions, comments and approval, thus 
ensuring the overall community ‘voice’ was represented as well as 
possible. With great thanks to all the forum members whose ideas, 
conversations and support for more research led to this study.
Funding  This research was part of a wider study funded by LUPUS 
UK.
Compliance with ethical standards 
Conflict of interest The authors declare there are no conflicts of inter-
est.
Ethical approval Ethical approval was obtained through the Cambridge 
Psychology Research Committee. PRE.2018.120.
Consent to participate A participant information sheet was made avail-
able on the forum. Consent to use individual forum quotes was obtained 
by LUPUS UK staff (CW).
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Gordon C, Amissah-Arthur MB, Gayed M et al (2017) The Brit-
ish Society for Rheumatology guideline for the management of 
systemic lupus erythematosus in adults. Rheumatology. https ://
doi.org/10.1093/rheum atolo gy/kex28 6
 2. Tektonidou M, Lewandowski L, Dasgupta A (2017) Survival in 
adults and children with systemic lupus erythematosus: a system-
atic review and Bayesian meta-analysis from 1950 to 2016. Ann 
Rheum Dis 76(12):2009–2016
 3. Kasitanon N, Magder M et al (2006) Predictors of survival in 
systemic lupus erythematosus. Medicine 85(3):p147-156
Rheumatology International 
1 3
 4. Kent T, Davidson A, D’Cruz D et al (2017) Burden of illness in 
systemic lupus erythematosus: results from a UK patient and carer 
online survey. Lupus 26:1095–1100
 5. Gordon C, Isenberg D, Lerstrom K et al (2013) The substantial 
burden of systemic lupus erythematosus on the productivity and 
careers of patients: a European patient- driven online survey. 
Rheumatology 52:2292–2301
 6. Philip EJ, Lindner H, Lederman L (2009) Relationship of illness 
perceptions with depression among individuals diagnosed with 
lupus. Depress Anxiety 26:575–582
 7. Buća A, Perković D, Martinović-Kaliterna D, Vlastelica M, Titlić 
M (2009) Neuropsychiatric systemic lupus erythematosus: diag-
nostic and clinical features according to revised ACR criteria. Coll 
Antropol 33(1):281–288
 8. Zhang L, Fu T, Yin R et al (2017) Prevalence of depression and 
anxiety in systemic lupus erythematosus: a systematic review and 
meta-analysis. BMC Psychiatry 17:1–14
 9. Booth S, Price E, Walker E (2018) Fluctuation, invisibility, 
fatigue-the barriers to maintaining employment with sys-
temic lupus erythematosus: results of an online survey. Lupus 
27(14):2284–2291
 10. Moses N, Wiggers J, Nicholas C, Cockburn J (2005) Prevalence 
and correlates of perceived unmet needs of people with systemic 
lupus erythematosus. Patient Educ Couns 57:30–38
 11. Sloan M, Harwood R, Sutton S, DCruz D, Howard P, Wincup C 
et al (2020) Medically explained symptoms: a mixed methods 
study of diagnostic, symptom and support experiences of patients 
with lupus and related systemic autoimmune diseases. Rheumatol 
Adv Pract. https ://doi.org/10.1093/rap/rkaa0 06
 12. Morgan C, Bland AR, Maker C, Dunnage J, Bruce IN (2018) Indi-
viduals living with lupus: findings from the LUPUS UK Members 
Survey 2014. Lupus 27:681–687
 13. Day C, Yeh A, Franco O et al (2007) Musculoskeletal medicine: 
an assessment of the attitudes and knowledge of medical students 
at Harvard medical school. Acad Med 82(5):452–457
 14. Akesson K et al (2003) Improved education in musculoskeletal 
conditions is necessary for all doctors. Bull World Health Organ 
81(9):677–683
 15. Feinmann J, Hopgood J, Lanyon P et al (2018) Reduce, improve, 
empower: report addressing the shared needs of rare autoimmune 
rheumatic diseases. Rare Autoimmune Rheumatic Disease Alli-
ance, London
 16. Sloan M, Naughton F, Harwood R, Lever E, DCruz D, Sutton 
S et al (2020) Is it me? The impact of patient-physician interac-
tions on lupus patients’ psychological wellbeing, cognitions, and 
healthcare-seeking behaviour. Rheumatol Adv Pract. https ://doi.
org/10.1093/rap/rkaa0 37
 17. World Health Organisation (2008) 2008–2013 Action plan for the 
global strategy for the prevention and control of noncommunica-
ble diseases. WHO, Geneva
 18. Dennis CL (2003) Peer support within a health care context: a 
conceptual analysis. Int J Nurs Stud 40(3):321–332
 19. Peery M, Watt-Watson J (2010) Peer support intervention trials 
for individuals with heart disease: a systematic review. Eur J Car-
diovasc Nurs 9(1):57–67
 20. Felten R, Sagez F, Gavand P-E et al (2019) 10 most important 
contemporary challenges in the management of SLE. Lupus Sci 
Med 6:e000303. https ://doi.org/10.1136/lupus -2018-00030 3
 21. Elera-Fitzcarrald C, Fuentes A, González LA, Burgos PI, Alarcón 
GS, Ugarte-Gil MF (2018) Factors affecting quality of life in 
patients with systemic lupus erythematosus: important consid-
erations and potential interventions. Expert Rev Clin Immunol 
14:915–931
 22. Georgopoulou S, Prothero L, DCruz DP (2018) Physician–patient 
communication in rheumatology: a systematic review. Rheumatol 
Int 38:763–775
 23. Jamison J, Sutton S, Mant J, De Simon A (2017) Barriers and 
facilitators to adherence to secondary stroke prevention medi-
cations after stroke: analysis of survivor and caregivers views 
from an online stroke forum. BMJ Open 7:e016814. https ://doi.
org/10.1136/bmjop en-2017-01681 4
 24. Pink S, Horst H, Postill J, Hjorth L, Lewsi T, Tacchi J (2016) 
Digital ethnography. Principles and Practices. SAGE Publications, 
London
 25. Braun V, Clarke V (2006) Using thematic analysis in psychology. 
Qual Res Psychol 3:77–101
 26. Seale C (1999) Grounding theory. In: Routledge A (ed) The qual-
ity of qualitative research. SAGE Publications Ltd, London, pp 
87–105
 27. Brennan K, Creaves A (2016) Living with invisible illness: social 
support experiences of individuals with SLE. Qual Life Res 
25(5):1227–1235
 28. Santiago M, Marques A, Kool M et al (2017) Invalidation in 
patients with rheumatic diseases: clinical and psychological 
framework. J Rheumatol 44(4):512–518
 29. Sutanto B, Singh-Grewal D, McNeil H (2013) Experience and 
perspectives of Adults living with SLE: thematic analysis of quali-
tative studies. Arthritis Care Res 65(11):1752–1765
 30. Haugli L, Strand E, Finset A (2004) How do patients with rheu-
matic disease experience their relationship with their doctors? A 
qualitative study of stress and support in the doctor-patient rela-
tionship. Patient Educ Couns 52:169–174
 31. Price E, Walker E (2014) Diagnostic vertigo: the journey to diag-
nosis in systemic lupus erythematosus. Health 18:223–239
 32. Turriff A, Macnamara E, Levy HP, Biesecker B (2017) The impact 
of living with Klinefelter syndrome: a qualitative exploration of 
adolescents and adults. J Genet Couns 26(4):728–737
 33. Hausmann J, Lomax K, Shapiro A et al (2018) The patient jour-
ney to diagnosis and treatment of autoinflammatory diseases. 
Orphanet J Rare Dis 13:156
 34. Nightingale AL, Davidson JE, Molta CT et al (2017) Presentation 
of SLE in UK primary care using the Clinical Practice Research 
Datalink. Lupus Sci Med 4:e000172. https ://doi.org/10.1136/
lupus -20160 00172 
 35. Hochberg M (1997) Updating the American College of Rheu-
matology revised criteria for the classification of systemic lupus 
erythematosus. Arthritis Rheum 40:1725–1725
 36. Petri M, Orbai A, Alarcon G (2012) Derivation and validation of 
the systemic lupus collaborating clinic’s classification criteria for 
systemic lupus erythematous. Arthritis Rheum 64:2677–2686
 37. Mol A (2002) The Body multiple: ontology in medical Practice. 
Duke University Press, Durham
 38. Stockl A (2007) Complex syndromes, ambivalent diagnosis and 
existential uncertainty: the case of systemic lupus erythematosus 
(SLE). Soc Sci Med 65:1549–1559
 39. Di Stadio A, Ralli M (2017) Systemic lupus erythematosus and 
hearing disorders: literature review and meta-analysis of clinical 
and temporal bone findings. J Int Med Res 45(5):1470–1480
 40. Duong Nha T, Moy B, Rezaizadeh H (2017) Rare manifestation 
of gastrointestinal lupus. Am J Gastroenterol 112:S1307
 41. Choudhury S, Ramos M, Anjum H et al (2020) Shrinking lung 
syndrome: a rare manifestation of systemic lupus erythematosus. 
Cureus 12(5):e8216. https ://doi.org/10.7759/cureu s.8216
 42. Mik-Meyer N (2010) An illness of one’s own: power and the nego-
tiation of identity among social workers, doctors, and patients 
without a bio-medical diagnosis. J Power 3(2):171–187
 43. Whitehead K, Williams J (2001) Medical treatment of women 
with lupus. The case for sharing knowledge and decision-making. 
Disbaility Soc 16(1):103–121
 44. Moss P, Dyck I (2002) Women, body, illness: space and identity 
in the everyday lives of women with chronic illness. Rowman and 
Littlefield Publishers, Lanham
 Rheumatology International
1 3
 45. Hadert A, Rodham K (2008) The invisible reality of arthritis: a 
qualitative analysis of an online message board. Musculoskelet 
Care 6:181–196
 46. Basu A, Dutta MJ (2008) The Relationship between health infor-
mation seeking and community participation: the roles of health 
information orientation and efficacy. Health Commun 23:70–79
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
